Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EPCAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04009148
What this trial is testing

Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome

Who this might be right for
BRCA-Mutated Ovarian CarcinomaBRIP1 Gene MutationMSH2 A636P+5 more
NYU Langone Health 118
Not applicableStudy completedNCT06789224
What this trial is testing

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Who this might be right for
Bladder CarcinomaProstate TumorGallbladder Carcinoma+9 more
Lindis Bloodcare GmbH 136
Very early researchStudy completedNCT04379999
What this trial is testing

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Who this might be right for
Lynch Syndrome
Fox Chase Cancer Center 43
Early research (Phase 1)Looking for participantsNCT05808634
What this trial is testing

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Who this might be right for
Advanced Adenocarcinoma
BioAtla, Inc. 168
Testing effectiveness (Phase 2)UnknownNCT03013712
What this trial is testing

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

Who this might be right for
Colon CancerEsophageal CarcinomaPancreatic Cancer+3 more
First Affiliated Hospital of Chengdu Medical College 60
Early research (Phase 1)UnknownNCT02915445
What this trial is testing

EpCAM CAR-T for Treatment of Advanced Solid Tumors

Who this might be right for
Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M)Breast Cancer RecurrentGastric Cancer With Metastasis
Sichuan University 30
Early research (Phase 1)Study completedNCT06386653
What this trial is testing

Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

Who this might be right for
Lung CancerOvarian Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Not applicableActive Not RecruitingNCT02760849
What this trial is testing

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Who this might be right for
Deleterious BARD1 Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+11 more
M.D. Anderson Cancer Center 374
Early research (Phase 1)Study completedNCT00635596
What this trial is testing

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Who this might be right for
Solid Tumors
Amgen Research (Munich) GmbH 65
Early research (Phase 1)Study completedNCT00132522
What this trial is testing

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Who this might be right for
Ovarian CancerColorectal CancerCarcinoma, Non-small-cell Lung+1 more
EMD Serono 45
Testing effectiveness (Phase 2)Study completedNCT00189345
What this trial is testing

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Who this might be right for
Ovarian CancerFallopian Tube NeoplasmsPeritoneal Neoplasms
AGO Study Group 44
Not applicableLooking for participantsNCT07450612
What this trial is testing

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

Who this might be right for
Colorectal CancerAdenoma ColonAdenoma Colon Polyp+16 more
San Raffaele University 1,200
Large-scale testing (Phase 3)Study completedNCT00822809
What this trial is testing

CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers

Who this might be right for
CancerNeoplasmsCarcinoma+1 more
Neovii Biotech 230
Early research (Phase 1)Study completedNCT05620472
What this trial is testing

Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1

Who this might be right for
Solid Tumor, Adult
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Not applicableStudy completedNCT00568282
What this trial is testing

Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients

Who this might be right for
Lung Cancer
Stanford University 219
Not applicableLooking for participantsNCT06708429
What this trial is testing

Lynch Syndrome X-Talk of Enteral Mucosa With Immune System

Who this might be right for
Lynch SyndromeLynch Syndrome ILynch Syndrome II+19 more
San Raffaele University 300
Early research (Phase 1)Enrolling By InvitationNCT07784660
What this trial is testing

Molecular Imaging of EpCam Expression in Breast Cancer Using [99mTc]Tc-DARPinEc1-G3C

Who this might be right for
Primary Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Early research (Phase 1)Ended earlyNCT00481936
What this trial is testing

Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

Who this might be right for
Neoplasms, Glandular and Epithelial
Sesen Bio, Inc. 15
Early research (Phase 1)Study completedNCT04501744
What this trial is testing

M701 (EpCAM and CD3) in Malignant Ascites

Who this might be right for
Malignant AscitesCancer
Wuhan YZY Biopharma Co., Ltd. 35
Testing effectiveness (Phase 2)Study completedNCT01504256
What this trial is testing

Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas

Who this might be right for
Gastric Adenocarcinoma With Peritoneal CarcinomatosisSiewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal CarcinomatosisSiewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis
AIO-Studien-gGmbH 42
Next Page